Sign in
4

Changes in Ownership

Design Therapeutics, Inc. Filed Acc 0001209191-22-020637

Director sold 590,880 shares at an average $19.07 ($11,266,197)

From the SEC's structured data for this filing

Trades in this filing

Xu Stella · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-18 Sale : show line 1 in the form −552,225 $19.04 $10,514,364 4,168,605 I
2022-03-18 Sale : show line 2 in the form −13,200 $20.34 $268,488 4,155,405 I
2022-03-21 Sale : show line 3 in the form −24,000 $19.01 $456,240 4,131,405 I
2022-03-22 Sale : show line 4 in the form −1,455 $18.63 $27,105 4,129,950 I
Open-market sales · 590,880 sh · avg $19.07 · $11,266,197
Loading xslF345X03/doc4.xml…